The European Union has announced more than 200 million euros to tackle the new crown variant

Pharma Network February 18, with the continued spread of new crown variant strains, the European Union announced on the 17th to invest more than 200 million euros to increase the identification and research of new crown variant strains, the same day also announced the purchase of 300 million doses of Modner new crown vaccine.
The European Commission announced on the same day that the European Union will invest a total of 225 million euros to address the risk posed by the new coronavirus strain, of which 75 million euros will be used to help member states improve gene sequencing capacity, the proportion of new coronavirus test positive samples subject to genome sequencing from the current about 1% to 5%, so as to identify the new crown variant strains in a timely manner, monitoring their transmission rate and disease in the population.
The remaining 150 million euros will be used to support research and exchange data on new crown variant strains, including the EUROPEAN Union's convening of 16 member states and five countries, including Switzerland and Israel, to create a clinical trial network platform where participating countries can exchange data and gradually integrate children and young people into clinical trial subjects. the
announcement quoted European Commission President Jean-Claude von der Leyen as saying that the current emergence of new crown variants, the European Union must make adjustments as soon as possible to get ahead of the virus, the 17th announced a package of plans to bring together the scientific community, industry and government departments to mobilize all available resources to fight the epidemic.
17th, the European Commission also announced that on the basis of last November's order of 160 million doses of vaccine, the European Union and Modner reached a second agreement to buy an additional 300 million doses of Modner new crown vaccine, so that the total order of new crown vaccine in the European Union increased to 2.6 billion doses.
the European Union did not disclose when Modner would deliver the vaccines.
On January 6 this year, the European Union approved the use of the New Crown vaccine in Modner, allowing it to be marketed in the European Union, but in late January Modner informed it that it would not be able to deliver enough vaccines outside the United States "in the short term" because of capacity changes by its Swiss-based partners.
, Italy, France, Switzerland, Canada and other countries confirmed that the New Crown vaccine received in February would be one to two percent less than originally planned.
(Complete)